Christian Health Association of Kenya (CHAK), P.O. Box 30690 - 00100, GPO, Nairobi, Kenya.
Department of Clinical Medicine & Therapeutics, University of Nairobi, P.O. Box 19676 - 00202, Nairobi, Kenya.
BMC Public Health. 2021 Mar 23;21(1):569. doi: 10.1186/s12889-021-10587-1.
Early infant diagnosis (EID) of HIV, followed by effective care including antiretroviral therapy (ART), reduces infant mortality by 76% and HIV progression by 75%. In 2015, 50% of 1.2 million HIV-exposed infants (HEI) in 21 priority countries received a virologic test within the recommended 2 months of birth. We sought to identify factors associated with timely uptake of virologic EID among HEI and gain insight into missed opportunities.
This was a cross-sectional study that used de-identified data from electronic medical records of 54 health facilities within the Christian Health Association of Kenya (CHAK) HIV Project database. All HEI who had their first HIV virologic test done between January 2015 and December 2017 were included in the study and categorized as either having the test within or after 8 weeks of birth. Multivariate linear mixed effects regression model was used to determine factors associated with uptake of the first HIV EID polymerase chain reaction (PCR). Predictor variables studied include sex, birth weight, the entry point into care, provision of ART prophylaxis for the infant, maternal ART at time of EID, mode of delivery, and place of delivery.
We included 2020 HEI of whom 1018 (50.4%) were female. A majority, 1596 (79.0%) had their first HIV PCR within 2 months of birth at a median age of 6.4 weeks (interquartile range 6-7.4). Overall, HIV positivity rate at initial test among this cohort was 1.2%. Delayed HIV PCR testing for EID was more likely to yield a positive result [adjusted odds ratio (aOR) = 1.29 (95% confidence interval (CI) 1.09-1.52) p = 0.003]. Infants of mothers not on ART at the time of HIV PCR test and infants who had not received prophylaxis to prevent vertical HIV transmission had significant increased odds of a delayed initial test [aOR = 1.27 (95% CI = 1.18-1.37) p = < 0.0001] and [aOR = 1.43 (95% CI 1.27-1.61) p = < 0.001] respectively.
An initial HIV PCR test done after 8 weeks of birth is likely to yield a positive result. Barriers to accessing ART for treatment among HIV-infected pregnant and breastfeeding women, and prophylaxis for the HEI were associated with delayed EID. In order to ensure timely EID, programs need to incorporate both facility and community strategy interventions to ensure all pregnant women seek antenatal care and deliver within health facilities.
早期婴儿诊断(EID)HIV 后,进行有效的护理,包括抗逆转录病毒治疗(ART),可将婴儿死亡率降低 76%,HIV 进展率降低 75%。2015 年,在 21 个重点国家中,有 120 万 HIV 暴露婴儿(HEI)中的 50%在出生后 2 个月内接受了病毒学检测。我们旨在确定与 HEI 及时进行病毒学 EID 相关的因素,并深入了解错过的机会。
这是一项横断面研究,使用了肯尼亚基督教健康协会(CHAK)HIV 项目数据库中电子病历的匿名数据。所有在 2015 年 1 月至 2017 年 12 月期间进行首次 HIV 病毒学检测的 HEI 均纳入研究,并分为出生后 8 周内或之后进行检测的两组。使用多变量线性混合效应回归模型确定与首次 HIV EID 聚合酶链反应(PCR)检测相关的因素。研究的预测变量包括性别、出生体重、进入护理的切入点、为婴儿提供 ART 预防、EID 时产妇的 ART、分娩方式和分娩地点。
我们纳入了 2020 名 HEI,其中 1018 名(50.4%)为女性。大多数(1596 名,占 79.0%)在出生后 2 个月内进行了首次 HIV PCR 检测,中位年龄为 6.4 周(四分位距 6-7.4)。总体而言,该队列中初始检测的 HIV 阳性率为 1.2%。EID 后 HIV PCR 检测延迟更有可能产生阳性结果[调整优势比(aOR)=1.29(95%置信区间(CI)1.09-1.52),p=0.003]。在 HIV PCR 检测时未接受 ART 的母亲所生婴儿和未接受预防垂直 HIV 传播的婴儿,初始检测延迟的可能性显著增加[aOR=1.27(95% CI=1.18-1.37),p=<0.0001]和[aOR=1.43(95% CI 1.27-1.61),p=<0.001]。
出生后 8 周进行的首次 HIV PCR 检测可能产生阳性结果。获得 HIV 感染孕妇和哺乳期妇女的 ART 治疗以及 HEI 预防的机会受限,与 EID 延迟有关。为了确保及时进行 EID,项目需要将设施和社区策略干预措施结合起来,以确保所有孕妇都能获得产前护理并在医疗机构分娩。